Literature DB >> 2416320

The role of mitomycin antibiotics in the chemotherapy of solid tumors.

A C Sartorelli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2416320     DOI： 10.1016/0006-2952(86)90559-9

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  10 in total

1.  Effects of photochemically activated alkylating agents of the FR900482 family on chromatin.

Authors:  Vidya Subramanian; Pascal Ducept; Robert M Williams; Karolin Luger
Journal:  Chem Biol       Date:  2007-05

2.  Stereoselective synthesis of complex polycyclic aziridines: use of the Brønsted acid-catalyzed aza-Darzens reaction to prepare an orthogonally protected mitomycin C intermediate with maximal convergency.

Authors:  Jayasree M Srinivasan; Priya A Mathew; Amie L Williams; John C Huffman; Jeffrey N Johnston
Journal:  Chem Commun (Camb)       Date:  2011-02-24       Impact factor: 6.222

3.  Enhancement of the efficacy of mitomycin C-mediated apoptosis in human colon cancer cells with RNAi-based thioredoxin reductase 1 deficiency.

Authors:  Preeyaporn Koedrith; Young Rok Seo
Journal:  Exp Ther Med       Date:  2011-06-30       Impact factor: 2.447

Review 4.  Activation mechanisms to chemical toxicity.

Authors:  D V Parke
Journal:  Arch Toxicol       Date:  1987       Impact factor: 5.153

5.  Thiol oxidation coupled to DT-diaphorase-catalysed reduction of diaziquone. Reductive and oxidative pathways of diaziquone semiquinone modulated by glutathione and superoxide dismutase.

Authors:  I D Ordoñez; E Cadenas
Journal:  Biochem J       Date:  1992-09-01       Impact factor: 3.857

6.  Mitomycin C is not metabolized by but is an inhibitor of human kidney NAD(P)H: (quinone-acceptor)oxidoreductase.

Authors:  J J Schlager; G Powis
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

7.  Effect of hyperthermia on the activity of 1-[(4'-hydroxy-2'-butenoxy)methyl]-2-nitroimidazole, which is cytotoxic to hypoxic cells.

Authors:  T Kusumoto; Y Maehara; Y Emi; Y Sakaguchi; H Baba; M Sakaguchi; K Sugimachi
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

Review 8.  Hypoxia and drug resistance.

Authors:  B A Teicher
Journal:  Cancer Metastasis Rev       Date:  1994-06       Impact factor: 9.264

9.  Enhancement of chemotherapy and nitroimidazole-induced chemopotentiation by the vasoactive agent hydralazine.

Authors:  D W Siemann
Journal:  Br J Cancer       Date:  1990-09       Impact factor: 7.640

10.  Characterization of radiation resistant hypoxic cell subpopulations in KHT sarcomas. (II). Cell sorting.

Authors:  D W Siemann; P C Keng
Journal:  Br J Cancer       Date:  1988-09       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.